Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong.

Take two mins to learn more

BioCaptiva

BioCaptiva

BioCaptiva

BioCaptiva develops polymer-based technologies that efficiently capture cell-free DNA from biological samples. The platform improves sample preparation for liquid biopsy workflows, supporting earlier disease detection and monitoring.

BioCaptiva develops polymer-based technologies that efficiently capture cell-free DNA from biological samples. The platform improves sample preparation for liquid biopsy workflows, supporting earlier disease detection and monitoring.

A photo of a man holding a liquid biopsy device
A photo of a man holding a liquid biopsy device
A photo of gloved hands holding DNA samples

Why did we invest in

Why did we invest in

BioCaptiva

BioCaptiva

?

?

  • Differentiated technology: Direct-from-blood cfDNA extraction delivering higher yields, faster processing, and simplified automation-ready workflows.

  • Strong market tailwinds: Rapid growth in liquid biopsy and precision diagnostics is increasing demand for improved pre-analytical solutions.

  • Clear competitive advantage: Demonstrated performance superiority versus gold-standard extraction methods with improved consistency and workflow efficiency.

  • Commercial potential: Early engagement with diagnostics OEMs, research labs, and industry partners supporting the scalable adoption and strategic exit pathways.


Get in Touch with Our Team.

Get in Touch with Our Team.

Get in Touch with Our Team.

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by